Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional

Safety, Efficacy, and Pharmacokinetics (PK) Study of Trans Sodium Crocetinate (TSC) in Patients With Intermittent Claudication

ClinicalTrials.gov ID: NCT00725881

Public ClinicalTrials.gov record NCT00725881. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 11:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blinded, Placebo-Controlled Phase 1/2 Dose-Range-Finding Study to Evaluate the Safety, Efficacy and PK of Multiple Once Daily Intravenous Doses of TSC in Patients With Intermittent Claudication

Study identification

NCT ID
NCT00725881
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Diffusion Pharmaceuticals Inc
Industry
Enrollment
48 participants

Conditions and interventions

Interventions

  • Trans sodium crocetinate (TSC) Drug
  • 0.9% normal saline Drug

Drug

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2008
Primary completion
Feb 28, 2010
Completion
Feb 28, 2010
Last update posted
Jul 28, 2011

2008 – 2010

United States locations

U.S. sites
7
U.S. states
6
U.S. cities
7
Facility City State ZIP Site status
Cardiology, P.C. Birmingham Alabama 35211
Radiant Research, Inc. Santa Rosa California 95405
Stanford University School of Medicine, Division of Cardiovascular Medicine Stanford California 94305-5406
Andrews Research and Education Pensacola Florida 32561
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104
Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104
Clinical Trials of Texas, Inc. San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00725881, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 28, 2011 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00725881 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →